Pirfenidone and Lung infection - a phase IV clinical study of FDA data

Summary:

Lung infection is reported as a side effect among people who take Pirfenidone (pirfenidone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Esbriet, and have Idiopathic pulmonary fibrosis.

The phase IV clinical study analyzes which people have Lung infection when taking Pirfenidone. It is created by eHealthMe based on reports of 2,647 people who have side effects when taking Pirfenidone from the FDA, and is updated regularly.

What is Pirfenidone?

Pirfenidone has active ingredients of pirfenidone. eHealthMe is studying from 2,648 Pirfenidone users. Check the latest studies of Pirfenidone.

What is Lung infection?

Lung infection is found to be associated with 1,065 drugs and 1,316 conditions by eHealthMe. Check the latest studies of Lung infection.

On Jul, 16, 2026

2,647 people reported to have side effects when taking Pirfenidone.
Among them, 15 people (0.57%) have Lung infection.

Among these 15 people:

How long have people been on Pirfenidone when they have Lung infection? *

What is the gender of people who have Lung infection when taking Pirfenidone? *

female: 20 %
male: 80 %

What is the age of people who have Lung infection when taking Pirfenidone? *

What are other drugs people take besides Pirfenidone? *

What are other side effects people have besides Lung infection? *

Dyspnea (difficult or laboured breathing): 9 people, 60.00%
Abdominal Discomfort: 8 people, 53.33%
Diarrhea: 8 people, 53.33%
Lower Respiratory Tract Infection: 8 people, 53.33%
Weakness: 8 people, 53.33%
Heart Rate Increased: 8 people, 53.33%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 53.33%
Fatigue (feeling of tiredness): 8 people, 53.33%
Dizziness: 8 people, 53.33%
Nasopharyngitis (inflammation of the nasopharynx): 8 people, 53.33%

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 12 people, 80.00%
Osteomyelitis (infection of bone): 6 people, 40.00%
Respiratory Tract Infection: 2 people, 13.33%
Respiratory Disorder (respiratory disease): 2 people, 13.33%
Productive Cough: 2 people, 13.33%
Obliterative Bronchiolitis (bronchiolar inflammation): 2 people, 13.33%
Intervertebral Disc Disorder (spinal disc disorder): 2 people, 13.33%
Infection: 2 people, 13.33%
High Blood Cholesterol: 2 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pirfenidone and have Lung infection?

- Check whether Lung infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pirfenidone:

Pirfenidone (2,648 reports)

Lung infection treatments and more:

Lung infection (25,183 reports)

Browse all side effects of Pirfenidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung infection:

Lung infection (1,065 drugs)

Browse all the conditions that are associated with Lung infection:

Lung infection (1,316 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pirfenidone (the active ingredients of Pirfenidone) and Pirfenidone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.